Gland Pharma Ltd (GLAND) — shareholding pattern, promoter holding, financials and share price

Gland Pharma Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as GLAND and on the BSE under scrip code 543245. Its ISIN is INE068V01023.

Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped us witness exponential growth. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major.

Gland Pharma Limited is a prominent player in the global generic injectables market, operating under a B2B model with essential services like contract development and manufacturing across various systems.

The company achieved broad-based revenue growth of 22% YoY in Q3 FY26, reaching INR 16,954 million, driven by both its expansion and integration of Cenexi in France.

Listed peers in Pharmaceuticals: Ipca Laboratories Ltd, Ajanta Pharma Ltd, Glaxosmithkline Pharmaceuticals Ltd, J B Chemicals & Pharmaceuticals Ltd, Emcure Pharmaceuticals Ltd, Wockhardt Ltd.